Wuxi Biologics (02269.HK) announced that since 23 August this year, Tu Ming has been appointed as the Joint Chief Financial Officer and Executive Vice President of the Group, reporting to the Group Chief Financial Officer and Executive Vice President Lu Shaohua. Tu Ming will be responsible for leading the company's financial strategy, performance, reporting and business planning, as well as operational support work such as capital, tax, accounting management and audit.
藥明生物(02269.HK)委任聯席首席財務官
Wuxi Biologics (02269.HK) appoints Joint Chief Financial Officer
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.